#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	5494	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2341	682.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1495	1495	C	794	C,T,A	686,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	5494	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2341	682.7	0	HET	.	.	.	C207T	.	207	207	C	518	518	C	728	C,T	486,133	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8372	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4104	611.2	0	.	n	.	0	T695C	SNP	695	695	T	1372	1372	C	624	C,T,A	525,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8372	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4104	611.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2315	2315	G	786	G,T	688,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8372	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4104	611.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2648	2648	C	755	C,T	654,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8372	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4104	611.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3274	3274	T	723	T	601	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8372	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4104	611.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2722	2722	A	790	A	691	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	838	folP	855	855	100.0	folP.l6.c4.ctg.1	2048	122.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1273	1275	AGC	164;164;165	A;G;C	141;145;139	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1968	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3987	148.1	1	SNP	p	S91F	1	.	.	271	273	TTC	912	914	TTC	159;160;162	T;T;C	136;139;143	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1968	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3987	148.1	1	SNP	p	D95G	1	.	.	283	285	GGC	924	926	GGC	161;161;162	G;G,A;C	142;142,1;144	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1968	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3987	148.1	1	SNP	p	G95N	0	.	.	283	285	GGC	924	926	GGC	161;161;162	G;G,A;C	142;142,1;144	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	738	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1768	125.1	1	SNP	p	G45D	0	.	.	133	135	GGC	643	645	GGC	214;215;218	G,T;G;C,A	181,1;181;181,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	546	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1350	121.0	0	.	n	.	0	A197.	DEL	197	197	A	750	750	A	215	A	186	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1864	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3448	161.9	1	SNP	p	D86N	0	.	.	256	258	GAC	790	792	GAC	199;198;198	G;A;C	167;164;164	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1864	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3448	161.9	1	SNP	p	R87W	0	.	.	259	261	CGT	793	795	CGT	198;198;198	C;G,A;T	170;169,1;163	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1864	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3448	161.9	1	SNP	p	R87I	0	.	.	259	261	CGT	793	795	CGT	198;198;198	C;G,A;T	170;169,1;163	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1864	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3448	161.9	1	SNP	p	S87R	1	.	.	259	261	CGT	793	795	CGT	198;198;198	C;G,A;T	170;169,1;163	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1864	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3448	161.9	1	SNP	p	S88P	0	.	.	262	264	TCC	796	798	TCC	197;197;196	T,G;C,T,A;C	164,3;162,2,1;177	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1574	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3260	144.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1835	1837	GGC	182;183;182	G;G,C;C	160;158,1;158	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1423	1425	GCC	172;172;173	G;C;C	147;142;144	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1426	1428	ATG	173;172;174	A;T;G	150;144;142	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1438	1440	ACC	173;172;173	A;C;C	148;145;145	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1438	1440	ACC	173;172;173	A;C;C	148;145;145	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1939	1941	ACC	187;187;188	A;C;C	173;165;168	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1993	1995	GCG	187;186;187	G,T;C;G	163,1;162;165	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1993	1995	GCG	187;186;187	G,T;C;G	163,1;162;165	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2116	2118	GGT	176;177;177	G;G;T	153;154;150	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2125	2127	AGC	179;179;177	A,C;G;C	154,1;155;154	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1310	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2701	144.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2143	2145	CCG	172;172;171	C;C,T;G	139;144,1;137	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1562	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3591	130.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1840	1842	CCG	132;132;132	C;C;G	102;107;103	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	998	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2320	128.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	835	835	C	157	C	131	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1014	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1926	156.5	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	558	560	CAG	217;215;214	C;A,C,G;G	183;175,1,1;179	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1014	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1926	156.5	1	SNP	p	G120K	1	.	.	358	360	AAG	798	800	AAG	213;210;210	A,G,C;A,G;G,C	187,1,1;184,1;183,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1014	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1926	156.5	1	SNP	p	N121D	0	.	.	361	363	AAC	801	803	AAC	210;209;208	A;A,G;C	184;182,1;185	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1014	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1926	156.5	1	SNP	p	A121N	1	.	.	361	363	AAC	801	803	AAC	210;209;208	A;A,G;C	184;182,1;185	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3282	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5349	184.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	498	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1425	104.8	1	SNP	p	V57M	1	.	.	169	171	ATG	746	748	ATG	191;191;191	A;T;G	165;160;159	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
